Our CEO, Nicki Thompson, participated in a panel discussion on ‘Innovations in Protein Degradation in the Biotech Sector’ at Discovery on Target in Boston, highlighting how novel degrader modalities are driving innovation and enabling pursuit of challenging targets.
#BostonDOT #TPD
Abhishek Chatterjee @achemsynbio.bsky.social and Michael Krogh Jensen's talks are opening the afternoon session of SynBio @ #BostonDOT
SynBio @ #BostonDOT started with a fantastic morning session, with talks from Farren Isaacs, Shira @shiraweingarten.bsky.social, and Ryan Clarke
Next week, #Jordi_Mestres will be an invited speaker at the #BostonDOT, one of the industry's preeminent event on novel drug targets and technologies. 🚀
👉 www.discoveryontarget.com/ai-ml-enable...
We look forward to his contribution to this prestigious event!
#DiscoveryOnTarget #Boston #AI #ML
Next week our CEO Nicki Thompson will be in Boston for Discovery on Target.
Arrange a meeting: trimtechtherapeutics.com/contact/
#BostonDOT
Excited to chair #BostonDOT 's SynBio symposium with talks from
🔸Farren Isaacs
🔸Jessica Stark @jcstark.bsky.social
🔸Shira Weingarten-Gabbay @shiraweingarten.bsky.social
🔸Abhishek Chatterjee @achemsynbio.bsky.social
🔸Wen Tseng
🔸Michael Krogh Jensen
🔸Ryan Clarke
🔸Alex Reis @alexcampreis.com
